Vaxart, a biotech company developing oral vaccines, will release its Q3 2026 financial results on November 5 after market close. The next day, November 6 at 4:30 p.m. ET, Vaxart's senior management will hold a virtual fireside chat to answer stockholder questions. The company focuses on oral recombinant vaccines that can be taken as pills without refrigeration, targeting diseases like coronavirus, norovirus, influenza, and HPV. Investors can access the chat live or via replay on Vaxart's website.
Vaxart's upcoming stockholder fireside chat is noted here with Pluang's health sector market context as of Oct 29, 2026 18:11 WIB: Among 150 priced health-sector US stocks on Pluang, 95 rose and 47 fell today. Notable movers include Novartis AG (NVS) at USD 160.96 with a 3.13% increase and a typical hold time of 84 days, Sana Biotechnology Inc (SANA) at USD 2.71 up 3.04% but with 96% sell order activity and a 25-day hold time, and Gilead Sciences, Inc. (GILD) at USD 163.65 rising 2.80% with 87% buy order activity and a 114-day hold time.
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...
Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...
Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...
